EP2200616
MIPO-hindrar fyrir meðhöndlun á fettubrettusýki og fjölkerfavisnun
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
22.8.2008EP published:
26.12.2012EP application number:
08794174.6
EP translation filed:
19.2.2013Grant published:
15.3.2013EPO information:
European Patent Register
Max expiry date:
21.8.2028Expiry date:
21.8.2017
Title:
MIPO INHIBITORS FOR THE TREATMENT OF HUNTINGTON'S DISEASE AND MULTIPLE SYSTEM ATROPHY
Timeline
Today
22.8.2008EP application
26.12.2012EP Publication
19.2.2013Translation submitted
15.3.2013Registration published
21.8.2017Expires
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
ERIKSSON, HåkanAddress:
S-151 85 Södertälje, SE
Name:
POEWE, WernerAddress:
Innsbruck, AT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
957525 PDate:
23.8.2007Country:
US
Number:
957523 PDate:
23.8.2007Country:
US
Classification
Categories:
A61K 31/522, A61K 31/519, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 8.7.2013
Expires: 21.8.2014
Payer: Árnason Faktor
Number: 7
Paid: 31.7.2014
Expires: 21.8.2015
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 4.8.2015
Expires: 21.8.2016
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 7.7.2016
Expires: 21.8.2017
Payer: Árnason Faktor